HomePharmaceutical Global Biosimilar Monoclonal Antibodies (mAbs) Market Size, Share and Trends Analysis By Type, By Ap

Biosimilar Monoclonal Antibodies (mAbs) Market

Global Biosimilar Monoclonal Antibodies (mAbs) Market Size, Share and Trends Analysis By Type, By Application, By Region (North America, Europe, Asia Pacific, LAMEA) and Forecasts, 2025-2033

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Biosimilar Monoclonal Antibodies (mAbs) Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Biosimilar Monoclonal Antibodies (mAbs) Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Biosimilar Monoclonal Antibodies (mAbs) Market, By Product
    1. Introduction
      1. Market Size and Forecast, By Product
    2. Infliximab
      1. Market Size and Forecast, By Region
    3. Rituximab
      1. Market Size and Forecast, By Region
    4. Abciximab
      1. Market Size and Forecast, By Region
    5. Trastuzumab
      1. Market Size and Forecast, By Region
    6. Adalimumab
      1. Market Size and Forecast, By Region
    7. Bevacizumab
      1. Market Size and Forecast, By Region
    8. Others
      1. Market Size and Forecast, By Region
  10. Biosimilar Monoclonal Antibodies (mAbs) Market, By Applications
    1. Introduction
      1. Market Size and Forecast, By Applications
    2. Oncology
      1. Market Size and Forecast, By Region
    3. Chronic & Autoimmune Diseases
      1. Market Size and Forecast, By Region
    4. Others
      1. Market Size and Forecast, By Region
  11. Biosimilar Monoclonal Antibodies (mAbs) Market, By Distribution Channel
    1. Introduction
      1. Market Size and Forecast, By Distribution Channel
    2. Hospital Pharmacies
      1. Market Size and Forecast, By Region
    3. Retail Pharmacies
      1. Market Size and Forecast, By Region
    4. Online Pharmacies
      1. Market Size and Forecast, By Region
    5. Others
      1. Market Size and Forecast, By Region
  12. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. By Product
          1. Infliximab
            1. Rituximab
              1. Abciximab
                1. Trastuzumab
                  1. Adalimumab
                    1. Bevacizumab
                      1. Others
                      2. By Applications
                        1. Oncology
                          1. Chronic & Autoimmune Diseases
                            1. Others
                            2. By Distribution Channel
                              1. Hospital Pharmacies
                                1. Retail Pharmacies
                                  1. Online Pharmacies
                                    1. Others
                                  2. U.S.
                                    1. By Product
                                      1. Infliximab
                                        1. Rituximab
                                          1. Abciximab
                                            1. Trastuzumab
                                              1. Adalimumab
                                                1. Bevacizumab
                                                  1. Others
                                                  2. By Applications
                                                    1. Oncology
                                                      1. Chronic & Autoimmune Diseases
                                                        1. Others
                                                        2. By Distribution Channel
                                                          1. Hospital Pharmacies
                                                            1. Retail Pharmacies
                                                              1. Online Pharmacies
                                                                1. Others
                                                              2. Canada
                                                            2. Europe
                                                              1. Market Size and Forecast
                                                                1. By Product
                                                                  1. Infliximab
                                                                    1. Rituximab
                                                                      1. Abciximab
                                                                        1. Trastuzumab
                                                                          1. Adalimumab
                                                                            1. Bevacizumab
                                                                              1. Others
                                                                              2. By Applications
                                                                                1. Oncology
                                                                                  1. Chronic & Autoimmune Diseases
                                                                                    1. Others
                                                                                    2. By Distribution Channel
                                                                                      1. Hospital Pharmacies
                                                                                        1. Retail Pharmacies
                                                                                          1. Online Pharmacies
                                                                                            1. Others
                                                                                          2. U.K.
                                                                                            1. By Product
                                                                                              1. Infliximab
                                                                                                1. Rituximab
                                                                                                  1. Abciximab
                                                                                                    1. Trastuzumab
                                                                                                      1. Adalimumab
                                                                                                        1. Bevacizumab
                                                                                                          1. Others
                                                                                                          2. By Applications
                                                                                                            1. Oncology
                                                                                                              1. Chronic & Autoimmune Diseases
                                                                                                                1. Others
                                                                                                                2. By Distribution Channel
                                                                                                                  1. Hospital Pharmacies
                                                                                                                    1. Retail Pharmacies
                                                                                                                      1. Online Pharmacies
                                                                                                                        1. Others
                                                                                                                      2. Germany
                                                                                                                      3. France
                                                                                                                      4. Spain
                                                                                                                      5. Italy
                                                                                                                      6. Russia
                                                                                                                      7. Nordic
                                                                                                                      8. Benelux
                                                                                                                      9. Rest of Europe
                                                                                                                    2. APAC
                                                                                                                      1. Market Size and Forecast
                                                                                                                        1. By Product
                                                                                                                          1. Infliximab
                                                                                                                            1. Rituximab
                                                                                                                              1. Abciximab
                                                                                                                                1. Trastuzumab
                                                                                                                                  1. Adalimumab
                                                                                                                                    1. Bevacizumab
                                                                                                                                      1. Others
                                                                                                                                      2. By Applications
                                                                                                                                        1. Oncology
                                                                                                                                          1. Chronic & Autoimmune Diseases
                                                                                                                                            1. Others
                                                                                                                                            2. By Distribution Channel
                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                1. Retail Pharmacies
                                                                                                                                                  1. Online Pharmacies
                                                                                                                                                    1. Others
                                                                                                                                                  2. China
                                                                                                                                                    1. By Product
                                                                                                                                                      1. Infliximab
                                                                                                                                                        1. Rituximab
                                                                                                                                                          1. Abciximab
                                                                                                                                                            1. Trastuzumab
                                                                                                                                                              1. Adalimumab
                                                                                                                                                                1. Bevacizumab
                                                                                                                                                                  1. Others
                                                                                                                                                                  2. By Applications
                                                                                                                                                                    1. Oncology
                                                                                                                                                                      1. Chronic & Autoimmune Diseases
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. By Distribution Channel
                                                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                                                            1. Retail Pharmacies
                                                                                                                                                                              1. Online Pharmacies
                                                                                                                                                                                1. Others
                                                                                                                                                                              2. Korea
                                                                                                                                                                              3. Japan
                                                                                                                                                                              4. India
                                                                                                                                                                              5. Australia
                                                                                                                                                                              6. Singapore
                                                                                                                                                                              7. Taiwan
                                                                                                                                                                              8. South East Asia
                                                                                                                                                                              9. Rest of Asia-Pacific
                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                              1. Market Size and Forecast
                                                                                                                                                                                1. By Product
                                                                                                                                                                                  1. Infliximab
                                                                                                                                                                                    1. Rituximab
                                                                                                                                                                                      1. Abciximab
                                                                                                                                                                                        1. Trastuzumab
                                                                                                                                                                                          1. Adalimumab
                                                                                                                                                                                            1. Bevacizumab
                                                                                                                                                                                              1. Others
                                                                                                                                                                                              2. By Applications
                                                                                                                                                                                                1. Oncology
                                                                                                                                                                                                  1. Chronic & Autoimmune Diseases
                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                    2. By Distribution Channel
                                                                                                                                                                                                      1. Hospital Pharmacies
                                                                                                                                                                                                        1. Retail Pharmacies
                                                                                                                                                                                                          1. Online Pharmacies
                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                          2. UAE
                                                                                                                                                                                                            1. By Product
                                                                                                                                                                                                              1. Infliximab
                                                                                                                                                                                                                1. Rituximab
                                                                                                                                                                                                                  1. Abciximab
                                                                                                                                                                                                                    1. Trastuzumab
                                                                                                                                                                                                                      1. Adalimumab
                                                                                                                                                                                                                        1. Bevacizumab
                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                          2. By Applications
                                                                                                                                                                                                                            1. Oncology
                                                                                                                                                                                                                              1. Chronic & Autoimmune Diseases
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                2. By Distribution Channel
                                                                                                                                                                                                                                  1. Hospital Pharmacies
                                                                                                                                                                                                                                    1. Retail Pharmacies
                                                                                                                                                                                                                                      1. Online Pharmacies
                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                      2. Turky
                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                      1. Market Size and Forecast
                                                                                                                                                                                                                                        1. By Product
                                                                                                                                                                                                                                          1. Infliximab
                                                                                                                                                                                                                                            1. Rituximab
                                                                                                                                                                                                                                              1. Abciximab
                                                                                                                                                                                                                                                1. Trastuzumab
                                                                                                                                                                                                                                                  1. Adalimumab
                                                                                                                                                                                                                                                    1. Bevacizumab
                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                      2. By Applications
                                                                                                                                                                                                                                                        1. Oncology
                                                                                                                                                                                                                                                          1. Chronic & Autoimmune Diseases
                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                            2. By Distribution Channel
                                                                                                                                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                                                                                                                                1. Retail Pharmacies
                                                                                                                                                                                                                                                                  1. Online Pharmacies
                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                  2. Brazil
                                                                                                                                                                                                                                                                    1. By Product
                                                                                                                                                                                                                                                                      1. Infliximab
                                                                                                                                                                                                                                                                        1. Rituximab
                                                                                                                                                                                                                                                                          1. Abciximab
                                                                                                                                                                                                                                                                            1. Trastuzumab
                                                                                                                                                                                                                                                                              1. Adalimumab
                                                                                                                                                                                                                                                                                1. Bevacizumab
                                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                                  2. By Applications
                                                                                                                                                                                                                                                                                    1. Oncology
                                                                                                                                                                                                                                                                                      1. Chronic & Autoimmune Diseases
                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                        2. By Distribution Channel
                                                                                                                                                                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                                                                                                                                                                            1. Retail Pharmacies
                                                                                                                                                                                                                                                                                              1. Online Pharmacies
                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                              6. Rest of LATAM
                                                                                                                                                                                                                                                                                          2. Competitive Landscape, 2024
                                                                                                                                                                                                                                                                                            1. Introduction
                                                                                                                                                                                                                                                                                            2. Biosimilar Monoclonal Antibodies (mAbs) Market Share Analysis, 2024 (%)
                                                                                                                                                                                                                                                                                              1. Market Share Analysis, 2024
                                                                                                                                                                                                                                                                                              2. Competition Ranking, 2024
                                                                                                                                                                                                                                                                                              3. Key Developments & Growth Strategies
                                                                                                                                                                                                                                                                                                1. Merger & Acquisition
                                                                                                                                                                                                                                                                                                2. Product Launch
                                                                                                                                                                                                                                                                                                3. Expansion
                                                                                                                                                                                                                                                                                              4. Consolidated SWOT Analysis of Key Players
                                                                                                                                                                                                                                                                                          3. Company Profile
                                                                                                                                                                                                                                                                                            1. Pfizer Inc.
                                                                                                                                                                                                                                                                                              1. Business Overview
                                                                                                                                                                                                                                                                                              2. Financial Data
                                                                                                                                                                                                                                                                                              3. Key Product Categories
                                                                                                                                                                                                                                                                                              4. Recent Developments
                                                                                                                                                                                                                                                                                            2. Novartis AG
                                                                                                                                                                                                                                                                                            3. Amgen Inc.
                                                                                                                                                                                                                                                                                            4. Celltrion Inc.
                                                                                                                                                                                                                                                                                            5. Samsung Bioepis
                                                                                                                                                                                                                                                                                            6. Dr. Reddy’s Laboratories
                                                                                                                                                                                                                                                                                            7. Biocon Limited
                                                                                                                                                                                                                                                                                            8. Boehringer Ingelheim GmbH
                                                                                                                                                                                                                                                                                            9. Mylan N.V.
                                                                                                                                                                                                                                                                                            10. Teva Pharmaceutical Industries Ltd.
                                                                                                                                                                                                                                                                                            11. and others

                                                                                                                                                                                                                                                                                          Purchase Benefits

                                                                                                                                                                                                                                                                                          • Up to 6 months support
                                                                                                                                                                                                                                                                                          • Completely customizable scope
                                                                                                                                                                                                                                                                                          • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                          • Dedicated account manager
                                                                                                                                                                                                                                                                                          • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                          Report Snapshot
                                                                                                                                                                                                                                                                                          Order Now
                                                                                                                                                                                                                                                                                          Free Sample Report

                                                                                                                                                                                                                                                                                          "Find new revenue generation opportunities"